NextWave Pharmaceuticals - Ownership and Business Overview

Life ScienceCompany

NextWave Pharmaceuticals Ownership

Who owns NextWave Pharmaceuticals?

NextWave Pharmaceuticals is owned by Tris Pharma. It was acquired on September 25, 2018.

Was NextWave Pharmaceuticals formerly PE-backed?

Yes. NextWave Pharmaceuticals was formerly owned by 3 private investors.

NextWave Pharmaceuticals Business Overview

Where is NextWave Pharmaceuticals headquartered?

NextWave Pharmaceuticals is headquartered in Cupertino, California.

What sector is NextWave Pharmaceuticals in?

NextWave Pharmaceuticals is a life science company.

When was NextWave Pharmaceuticals founded?

NextWave Pharmaceuticals was founded in 2005.

Life Science M&A Summary in 2018

Out of 60 sectors in the Mergr database, life science ranked 7 in number of deals in 2018. The largest life science acquisition in 2018 was Shire - which was acquired by Takeda Pharmaceutical for $67.7B.

Join Mergr to view all 246 acquisitions of life science companies in 2018, including 44 acquisitions by private equity firms, and 202 by strategics.

NextWave Pharmaceuticals

NextWave Pharmaceuticals, Inc.

20450 Stevens Creek Boulevard, Suite 150,
Cupertino, California 95014
United States,
(408) 342-1300
www.nextwavepharma.com

NextWave Pharmaceuticals is a specialty pharmaceutical company developing extended release OTC and prescription products for children and adults. NextWave Pharmaceuticals was founded in 2005 and is based in Cupertino, California.


 Subscribe to unlock this and 201,688
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.5K Private Equity Firms
  • 193K M&A Transactions
  • 197K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 75K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.